Literature DB >> 11557581

Interaction of bacterial lipopolysaccharide with mouse surfactant protein C inserted into lipid vesicles.

L Augusto1, K Le Blay, G Auger, D Blanot, R Chaby.   

Abstract

Infection of the respiratory tract is a frequent cause of lung pathologies, morbidity, and death. When bacterial endotoxin [lipopolysaccharide (LPS)] reaches the alveolar spaces, it encounters the lipid-rich surfactant that covers the epithelium. Although binding of hydrophilic surfactant protein (SP) A and SP-D with LPS has been established, nothing has been reported to date on possible cross talks between LPS and hydrophobic SP-B and SP-C. We designed a new binding technique based on the incorporation of surfactant components to lipid vesicles and the separation of unbound from vesicle-bound LPS on a density gradient. We found that among the different hydrophobic components of mouse surfactant separated by gel filtration or reverse-phase HPLC, only SP-C exhibited the capacity to bind to a tritium-labeled LPS. The binding of LPS to vesicles containing SP-C was saturable, temperature dependent, related to the concentrations of SP-C and LPS, and inhibitable by distinct unlabeled LPSs. Unlike SP-A and SP-D, the binding of SP-C to LPS did not require calcium ions. This LPS binding capacity of SP-C may represent another antibacterial defense mechanism of the lung.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11557581     DOI: 10.1152/ajplung.2001.281.4.L776

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  8 in total

1.  Interaction of pulmonary surfactant protein C with CD14 and lipopolysaccharide.

Authors:  Luis A Augusto; Monique Synguelakis; Jan Johansson; Thierry Pedron; Robert Girard; Richard Chaby
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

2.  Molecular dynamics of surfactant protein C: from single molecule to heptameric aggregates.

Authors:  Eunice Ramírez; Alberto Santana; Anthony Cruz; Inés Plasencia; Gustavo E López
Journal:  Biophys J       Date:  2006-01-27       Impact factor: 4.033

3.  The N-terminal segment of pulmonary surfactant lipopeptide SP-C has intrinsic propensity to interact with and perturb phospholipid bilayers.

Authors:  Ines Plasencia; Luis Rivas; Kevin M W Keough; Derek Marsh; Jesús Pérez-Gil
Journal:  Biochem J       Date:  2004-01-01       Impact factor: 3.857

Review 4.  Pulmonary surfactant: an immunological perspective.

Authors:  Zissis C Chroneos; Zvjezdana Sever-Chroneos; Virginia L Shepherd
Journal:  Cell Physiol Biochem       Date:  2009-12-22

5.  SP-R210 (Myo18A) Isoforms as Intrinsic Modulators of Macrophage Priming and Activation.

Authors:  Linlin Yang; Marykate Carrillo; Yuchieh M Wu; Susan L DiAngelo; Patricia Silveyra; Todd M Umstead; E Scott Halstead; Michael L Davies; Sanmei Hu; Joanna Floros; Francis X McCormack; Neil D Christensen; Zissis C Chroneos
Journal:  PLoS One       Date:  2015-05-12       Impact factor: 3.240

Review 6.  Lipid-Protein and Protein-Protein Interactions in the Pulmonary Surfactant System and Their Role in Lung Homeostasis.

Authors:  Olga Cañadas; Bárbara Olmeda; Alejandro Alonso; Jesús Pérez-Gil
Journal:  Int J Mol Sci       Date:  2020-05-25       Impact factor: 5.923

7.  The detection of surfactant proteins A, B, C and D in the human brain and their regulation in cerebral infarction, autoimmune conditions and infections of the CNS.

Authors:  Stefan Schob; Martin Schicht; Saadettin Sel; Dankwart Stiller; Alexander S Kekulé; Alexander Kekulé; Friedrich Paulsen; Erik Maronde; Lars Bräuer
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

8.  Site-specific and endothelial-mediated dysfunction of the alveolar-capillary barrier in response to lipopolysaccharides.

Authors:  Harshavardhan Janga; Liam Cassidy; Fanlu Wang; Dietmar Spengler; Stefanie Oestern-Fitschen; Martin F Krause; Andreas Seekamp; Andreas Tholey; Sabine Fuchs
Journal:  J Cell Mol Med       Date:  2017-12-05       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.